The case studies included in the report are pertaining to Xoma, Dyax, Biocryst Pharmaceuticals, and TPG
Albany, NewYork (PRWEB) February 13, 2015
ResearchMoz has recently added a research document “Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics”. The report aims to fully explore and analyze how and who firms step into deals related to royalty financing.
Read Full Report With TOC @ http://www.researchmoz.us/royalty-financing-terms-and-agreements-in-pharma-biotech-and-diagnostics-report.html
The report provides descriptive access to more than 60 royalty financing deals that were made among biopharma companies around the globe. Details of contract documents are also provided whenever available.
Royalty financing details of more than 50 big pharma and big biotech firms have been provided access to, along with the top deal terms that companies had made agreements for in the past.
The available contracts in the Royalty Financing Partnering Terms and Agreements in Pharma, Biotech, and Diagnostics are compiled according to the company name, its headline value, and therapeutic area. The report provides a descriptive look at the royalty financing partnering terms and agreements in pharma, biotech, and diagnostics in terms of chapters.
The first chapter offers an introduction to the report. Chapter 2 goes deeper and analyzes the opportunities and challenges of royalty financing partnering terms and agreements in pharma, biotech and diagnostics. The report then deviates slightly from research analysis and moves on to case studies in chapter 3.
Chapter 4 lists the deals made in royalty financing since 2007. Each deal is presented according to headline value.
Chapters 5 and 6 both offer a detailed listing of all royalty financing deals and contracts that have been made since 2007. This includes deal value, press release data, and contract document. The sixth chapter is organized according to company A-Z and the therapeutic area.
The case studies included in the report are pertaining to Xoma, Dyax, Biocryst Pharmaceuticals, and TPG.
One of the key topics covered in the report is the overall trends in royalty financing deals within the biopharma industry. The trends are ordered chronologically, starting from the year 2007.
Request A Sample The Report @ http://www.researchmoz.com/enquiry.php?type=sample&repid=93012
The report also successfully analyzes the structure of royalty financing deals. This is done in part through real-life case studies regarding deals in royalty financing. The report goes further to display the full list of royalty financing deals since 2007. This list is arranged according to total value, making it easier for the user to prioritize the strategies involved.
The report also takes a detailed note of the most active dealmakers in royalty financing since 2007, along with discussing the resources in leading royalty financing partnering.
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
90 State Street,
Albany NY - 12207
USA - Canada Toll Free: 866-552-3453